|
(Click here for meetings with SEC officials)
|
| Sep. 8, 2016 | Ernst & Young LLP |
| Aug. 31, 2016 | Kermit Kubitz |
| Aug. 30, 2016 | Corporate Governance Coalition for Investor Value |
| Aug. 30, 2016 | Kurt N. Schacht, CFA, Managing Director, Standards and Advocacy, and Linda L. Rittenhouse, Director, Capital Markets Policy; CFA Institute |
| Aug. 30, 2016 | Joan Conley, Senior Vice President and Corporate Secretary, Nasdaq, Inc. |
| Aug. 30, 2016 | Ashley W. Wittorf, Executive Director, AdvaMed Accel, Washington, District of Columbia |
| Aug. 30, 2016 | Cynthia M. Fornelli, Executive Director, Center for Audit Quality, and Jeff Mahoney, General Counsel, Council of Institutional Investors |
| Aug. 30, 2016 | Charles Crain, Director, Tax & Financial Services Policy, and E. Cartier Esham, Executive Vice President, Emerging Companies; Biotechnology Innovation Organization |
| Aug. 29, 2016 | Christopher Cole, Executive Vice President and Senior Regulatory Counsel, Independent Community Bankers of America |
| Aug. 29, 2016 | BDO USA, LLP |
| Aug. 26, 2016 | Council of State Bioscience Associations |
| Aug. 25, 2016 | Bobby Franklin, President and CEO, National Venture Capital Association |
| Aug. 24, 2016 | C. R. Cloutier, President/Chief Executive Officer, MidSouth Bancorp, Inc. |
| Aug. 24, 2016 | Gerald S. Silberstein, PhD, CPA, MBA, CMA, Chair, Small Business Financial and Regulatory Affairs Committee, Institute of Management Accountants |
| Aug. 23, 2016 | Acorda Therapeutics, Inc., et al. |
| Aug. 23, 2016 | Deloitte & Touche LLP |
| Aug. 8, 2016 | William D. Waddill, Senior Vice President and Chief Financial Officer, Calithera Biosciences, Inc. |
| Aug. 4, 2016 | Greg McKee, CEO, CONNECT, San Diego, California |
| Aug. 2, 2016 | Timothy Benjamin, CFO, Seneca Foods Corporation |
| Jul. 25, 2016 | Thomas Farley, President, New York Stock Exchange |
| Jul. 18, 2016 | Paul W. Zeller, Esq. |
| Jul. 11, 2016 | Jon Faulkner, CFO, The Dixie Group, Inc. |
| Jun. 28, 2016 | Jacob Ma-Weaver, Managing Member, Cable Car Capital LLC, San Francisco, California |
Meetings with SEC Officials
(Click here for submitted comments from the public)
|
| Apr. 5, 2018 | Memorandum from the Office of Commissioner Kara M. Stein regarding an April 5, 2018, meeting with representatives of Biotechnology Innovation Organization |
| Mar. 29, 2018 | Memorandum from the Office of Commissioner Robert J. Jackson regarding a March 29, 2018, meeting with representatives of BIO |
| Feb. 21, 2018 |
Memorandum from the Office of Commissioner Michael S. Piwowar regarding a February 21, 2018, meeting with representatives of Biotechnology Innovation Organization
|
| Jan. 16, 2018 |
Memorandum from the Division of Corporation Finance regarding a January 16, 2018, meeting with representatives of Biotechnology Innovation Organization
|
